Form 4 for CRL Charles River Laboratories
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-15 · accession 0001127602-24-015691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-16 | 2024-05-15 | CRL | MASSARO GEORGE | Dir | S - Sale | $235.62 | -332 | 6,064 | -5% | -$78.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | S | D | 96 | $236.78 | 5,855 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $236.36 to $237.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2024-05-15 | S | D | 113 | $235.61 | 5,951 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $235.35 to $236.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan. |
| 3 | Common | Common Stock | 2024-05-15 | S | D | 123 | $234.72 | 6,064 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $234.27 to $235.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan. |